FDA Drug Application (021881) for MOVIPREP by SALIX PHARMS

Back to FDA Applications sponsored by SALIX PHARMS

Application Number021881
Product Number001
FormFOR SOLUTION;ORAL
Dosage4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMOVIPREP
Active IngredientASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE

Active IngredientCount
List of drugs with Active Ingredient ASCORBIC ACID15
List of drugs with Active Ingredient POLYETHYLENE GLYCOL 335028
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient SODIUM ASCORBATE2
List of drugs with Active Ingredient SODIUM CHLORIDE352
List of drugs with Active Ingredient SODIUM SULFATE9


Back to FDA Applications sponsored by SALIX PHARMS